BPG is committed to discovery and dissemination of knowledge
Featured Articles
Changes in lipid biomarkers, liver stiffness and steatosis following sodium-glucose cotransporter two inhibitor therapy in type two diabetes
Browse: 133   Download: 299   Issue Date: 2026-10-21
Gut microbiome in patients with cirrhosis and clinically significant portal hypertension: A pilot study
Browse: 118   Download: 342   Issue Date: 2026-10-21
Autoimmune hepatitis in the context of systemic lupus erythematosus: A narrative review of overlap syndrome and lupus-associated hepatitis
Browse: 113   Download: 249   Issue Date: 2026-10-21
Imbalance of the coagulation-anticoagulation-fibrinolytic system: Pathogenesis and therapeutic approaches in progressive liver injury
Browse: 107   Download: 246   Issue Date: 2026-10-21
Hyperammonemia as a potential contributor to fatigue in metabolic dysfunction-associated steatotic liver disease: A mechanistic review
Browse: 109   Download: 262   Issue Date: 2026-10-21
Splenic stiffness measurement to predict decompensation in compensated advanced chronic liver disease
Browse: 158   Download: 545   Issue Date: 2026-09-17
From virological selection to immune stratification: Hepatitis B virus-specific T cells for precision pegylated interferon therapy in chronic hepatitis B
Browse: 119   Download: 408   Issue Date: 2026-09-17
Hepatocellular carcinoma with obstructive jaundice: Biliary drainage and multimodal therapy
Browse: 135   Download: 378   Issue Date: 2026-09-17
Molecular characteristics and carcinogenic mechanisms of aflatoxin B1-associated hepatocellular carcinoma: Recent advances
Browse: 113   Download: 419   Issue Date: 2026-09-17
Predicting pancreatic fistula risk after splenectomy in cirrhotic splenomegaly: Surgical anatomy and implications
Browse: 111   Download: 376   Issue Date: 2026-09-17
Letter to the Editor: Filling the gaps in non-invasive assessment of liver fibrosis in metabolic dysfunction-associated steatotic liver disease
Browse: 143   Download: 621   Issue Date: 2026-08-18
Prevalence and risk factors for metabolic dysfunction-associated steatotic liver disease and fibrosis in recently diagnosed type 2 diabetes
Browse: 120   Download: 769   Issue Date: 2026-08-18
Effect of hepatic venous pressure gradient in different hepatic venous branches on assessing portal hypertension in cirrhotic patients
Browse: 116   Download: 878   Issue Date: 2026-08-18
Metabolic dysfunction-associated steatotic liver disease and the consequence of extra-hepatic malignancy
Browse: 151   Download: 455   Issue Date: 2026-08-18
Peribiliary and colonic crypt glands in primary sclerosing cholangitis and inflammatory bowel disease pathogenesis: New research perspectives
Browse: 103   Download: 550   Issue Date: 2026-08-18
Poria in Fuling Zexie decoction for treating metabolic dysfunction-associated steatotic liver disease: Underlying mechanisms and key bioactive substances
Browse: 168   Download: 969   Issue Date: 2026-07-24
Activated cGAS-STING signaling promotes malignancy in metabolic dysfunction-associated fatty liver disease via mitochondrial DNA and immune cell dysfunction
Browse: 146   Download: 909   Issue Date: 2026-07-24
Saroglitazar ameliorates alcoholic liver disease and is associated with enhanced ethanol metabolism
Browse: 178   Download: 900   Issue Date: 2026-07-24
Computed tomography-based correction of the body mass index improves malnutrition detection in patients with cirrhosis and ascites
Browse: 144   Download: 935   Issue Date: 2026-07-24
Translational potential of the interleukin-6/interleukin-10 ratio for immune monitoring after radiofrequency ablation
Browse: 151   Download: 764   Issue Date: 2026-07-24
Write to the Help Desk